Bio-Techne

Behind the scenes in Düsseldorf! Our teams are hard at work bringing our new Customer Experience Center in Germany to life. We’re excited for our demonstration lab to open next year, giving customers the chance to experience our innovations firsthand. As we prepare for this exciting launch, we’ll be growing our team in Düsseldorf over the coming months. If you're passionate about catalyzing advances in science and medicine and want to be part of this journey, keep an eye on our careers page for opportunities!

Innovation is a team effort - and our channel partners are essential to delivering the latest Bio-Techne innovations to researchers worldwide.    This week, our regional leadership team met with channel partners from across Europe, the Middle East and Africa (EMEA) in Istanbul, Türkiye, to align on how we can continue bringing cutting-edge solutions to customers and driving shared success. Together, we’re strengthening Bio-Techne’s global footprint, unlocking new opportunities and enabling exciting research in high-growth areas, from cell and gene therapy to spatial biology.  

“Purposeful innovation starts with people who never stop learning.” Hear from Michael Smith, Ed.D., Senior Leader, Talent Development, about our recent Career Development Week - designed to build skills, spark new ideas, and empower employees to continually push the boundaries of what’s possible to advance science and medicine.   #CareerDevelopment  

We are partnering with Saguaro Biosciences to distribute their live-cell imaging reagents.   By leveraging our extensive international sales and marketing channels, we'll provide researchers worldwide with better access to Saguaro’s portfolio of non-toxic, wash-free dyes for enhanced drug insights.  Read the news from Saguaro Biosciences: https://lnkd.in/eMgPJnCr #CellImaging #LiveCellImaging

We were honored to host Dr. Lawrence Fong, M.D., Scientific Director at Fred Hutchinson Cancer Center, for an inspiring session on how innovative immunotherapies are transforming cancer care.    Dr. Fong shared insights from his groundbreaking work, explored how researchers are overcoming resistance to treatment, and inspired us with what’s coming next - from bigger and better biology to smarter drug combinations and the exciting interplay of therapeutics, diagnostics, and precision medicine.   His talk left our team energized about the role Bio-Techne plays in catalyzing advances in cancer research.   #CancerResearch #Immunotherapy #PrecisionMedicine

On Metastatic Breast Cancer Awareness Day, we celebrate the progress researchers are making in understanding advanced breast cancer, and the hope this progress is bringing to patients and their families.    As we move towards more personalized approaches to cancer care, Bio-Techne is committed to playing a role in delivering deeper research insights, including through our precision oncology solutions. By making available kits for targeted, ultra-sensitive monitoring of molecular mutations, such as ESR1, we’re opening doors to discoveries that may one day help guide treatment strategies and improve outcomes for patients with advanced breast cancer.   #CancerResearch #BreastCancerAwareness

Today, we announced our expanded agreement with Oxford Nanopore Technologies to accelerate the development of our genetics portfolio through 2032.     This extended collaboration builds on the successful launch of the AmplideX® Nanopore Carrier Plus Kit for genetic carrier screening and reflects our commitment to advancing the screening and diagnosis of genetic disorders.    By leveraging Oxford Nanopore’s platforms, we can develop genetic testing solutions that offer enhanced capabilities to laboratories worldwide.    Read the full press release: https://lnkd.in/djGYNXA6   #Genetics #Diagnostics #Sequencing #Nanopore 

We’re reinforcing our commitment to career development with a week-long series of interactive sessions and expert-led workshops to fuel curiosity and inspire continuous learning. Here’s a glimpse of the energy from our Minneapolis, Abingdon, and Tolochenaz sites, as our teams come together to learn, grow and own their career journeys! #CareerDevelopment

In case you missed it, watch our CEO Kim Kelderman and Director of Sustainability Erin Woodward highlight our key sustainability achievements from the past year and explore examples of sustainability in action at our headquarters in Minneapolis. #Sustainability #ESG

Live from #FestivalofBiologics! Our EMEA Market Development Manager, Jean-François Bellec, shared insights into Adeno-Associated Virus (AAV) characterization, a crucial process in developing AAV-based gene therapies. In this study, our team developed a workflow using advanced analytical techniques to examine the protein composition, structure, and genetic content of AAV particles. This approach helps improve AAV design and quality control, ultimately supporting the development of safer, more effective gene therapies for patients. #Biologics #GeneTherapy #AAV